🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Some professionals said the demand for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Some content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has removed violative content and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

Within moments of joining one group, a seller shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, messages display black plastic packages with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly serious health risks”.